Skip to main content
. 2019 Jan 9;17(3):2019–2030. doi: 10.3892/etm.2019.7163

Table IV.

Plasma S100B levels according to the TT and AA/AT variants of the rs2269422 polymorphism of receptor for advanced glycation end products.

S100B (pg/ml)

Group TT AA/AT
Control (n=90) 95.52±28.98 129.43±21.34
CAD (n=70) 201.24±32.68a 286.69±63.91a
a

P<0.05 vs. the control group. Values are expressed as the mean ± standard deviation. S100B, S100 calcium binding protein B; CAD, coronary artery disease.